The Week in Review: July 14 – July 21, 2017

Friday, July 21, 2017 News Recap 1) Vosevi Approved in US – Under Review in Canada Vosevi has just been approved in the USA to treat adults with chronic HCV genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose, combination tablet containing sofosbuvir, velpatasvir and a new drug, voxilaprevir. Vosevi is the first treatment approved for patients who have been previously treated with DAAs and failed treatment....

Hepatitis C: New Drugs Cure It, but Most People Don’t Know They Have It

Hepatitis C is a potentially deadly liver disease that affects an estimated 3.5 million people in the United States and up to 150 million worldwide. In fact, it kills more Americans than all other infectious diseases together! But in just the past few years, advances in treatment have been nothing short of astounding. A condition once treated with medication that caused serious side effects and delivered a low cure rate is now curable almost all of the t...

The Week in Review: May 19 – June 2, 2017

Friday, June 2, 2017 News Recap Boomers Should Be Tested Most of the HepC-related news last week from various agencies in the USA stressed the fact that Baby Boomers should be tested and that hepatitis C is a hidden and growing danger (GET TESTED: 1 in 30 baby boomers have Hepatitis C, 70 percent are unaware). In Canada voices of dissent can be heard regarding the federal government’s asinine decision NOT to test Boomers.  The decision was based ...